Literature DB >> 15743182

Synthesis of phosphonated carbocyclic 2'-oxa-3'-aza-nucleosides: novel inhibitors of reverse transcriptase.

Ugo Chiacchio1, Emanuela Balestrieri, Beatrice Macchi, Daniela Iannazzo, Anna Piperno, Antonio Rescifina, Roberto Romeo, Monica Saglimbeni, M Teresa Sciortino, Vincenza Valveri, Antonio Mastino, Giovanni Romeo.   

Abstract

Phosphonated carbocyclic 2'-oxa-3'-aza-nucleosides have been synthesized in good yields by 1,3-dipolar cycloaddition methodology. The cytotoxicity and the reverse transcriptase inhibitory activity of the obtained compounds have been investigated. Phosphonated carbocyclic 2'-oxa-3'-aza-nucleosides, while showing low levels of cytotoxicity, exert a specific inhibitor activity on two different reverse transcriptases, which is comparable with that of AZT, opening new perspectives on their possible use as therapeutic agents, in anti-retroviral and anti-HBV chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743182     DOI: 10.1021/jm049399i

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells.

Authors:  Claudia Matteucci; Francesca Marino-Merlo; Antonella Minutolo; Emanuela Balestrieri; Elena Valletta; Beatrice Macchi; Antonio Mastino; Sandro Grelli
Journal:  Cell Death Discov       Date:  2020-02-18

2.  Effect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro.

Authors:  Emanuela Balestrieri; Claudia Matteucci; Arianna Ascolani; Anna Piperno; Roberto Romeo; Giovanni Romeo; Ugo Chiacchio; Antonio Mastino; Beatrice Macchi
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

3.  Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors.

Authors:  Beatrice Macchi; Emanuela Balestrieri; Arianna Ascolani; Silva Hilburn; Fabiola Martin; Antonio Mastino; Graham P Taylor
Journal:  Viruses       Date:  2011-05-05       Impact factor: 5.048

4.  How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy.

Authors:  Amandine Pasquier; Sandrine Alais; Loic Roux; Maria-Isabel Thoulouze; Karine Alvarez; Chloé Journo; Hélène Dutartre; Renaud Mahieux
Journal:  Front Microbiol       Date:  2018-03-13       Impact factor: 5.640

5.  Synthesis and biological properties of 5-(1H-1,2,3-triazol-4-yl)isoxazolidines: a new class of C-nucleosides.

Authors:  Salvatore V Giofrè; Roberto Romeo; Caterina Carnovale; Raffaella Mancuso; Santa Cirmi; Michele Navarra; Adriana Garozzo; Maria A Chiacchio
Journal:  Molecules       Date:  2015-03-24       Impact factor: 4.411

Review 6.  Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview.

Authors:  Francesca Marino-Merlo; Emanuela Balestrieri; Claudia Matteucci; Antonio Mastino; Sandro Grelli; Beatrice Macchi
Journal:  Pathogens       Date:  2020-05-01

7.  Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells.

Authors:  Claudia Matteucci; Francesca Marino-Merlo; Antonella Minutolo; Emanuela Balestrieri; Elena Valletta; Beatrice Macchi; Antonio Mastino; Sandro Grelli
Journal:  Cell Death Discov       Date:  2020-02-18

8.  Novel Isoxazolidine and γ-Lactam Analogues of Homonucleosides.

Authors:  Dorota G Piotrowska; Iwona E Głowacka; Dominique Schols; Robert Snoeck; Graciela Andrei; Joanna Gotkowska
Journal:  Molecules       Date:  2019-11-06       Impact factor: 4.411

9.  Conversion of oximes to carbonyl compounds by triscetylpyridinium tetrakis(oxodiperoxotungsto) phosphate (PCWP)-mediated oxidation with hydrogen peroxide.

Authors:  Francesco P Ballistreri; Ugo Chiacchio; Antonio Rescifina; Gaetano Tomaselli; Rosa M Toscano
Journal:  Molecules       Date:  2008-06-01       Impact factor: 4.411

10.  Design, synthesis, antiviral and cytostatic evaluation of novel isoxazolidine nucleotide analogues with a carbamoyl linker.

Authors:  Kamil Kokosza; Jan Balzarini; Dorota G Piotrowska
Journal:  Bioorg Med Chem       Date:  2013-01-16       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.